Skip to main content
SpringerLink
Log in

Dupiliumab-related ocular AEs in patients with atopic dermatitis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jia Q-N, et al. Ocular Adverse Effects in Atopic Dermatitis Patients Treated With Dupilumab: A Bibliometric Analysis Frontiers in Medicine : 3 Mar 2022. Available from: URL: https://doi.org/10.3389/fmed.2022.802036

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dupiliumab-related ocular AEs in patients with atopic dermatitis. Reactions Weekly 1900, 8 (2022). https://doi.org/10.1007/s40278-022-12360-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-12360-8

Search

Navigation